EP 1011709 A1 20000628 - INHIBITION OF APOPTOTIS USING PROSAPOSIN RECEPTOR AGONISTS
Title (en)
INHIBITION OF APOPTOTIS USING PROSAPOSIN RECEPTOR AGONISTS
Title (de)
APOPTOSEHEMMUNG DURCH PROSAPOSIN REZEPTORAGONISTEN
Title (fr)
INHIBITION DE L'APOPTOSE AU MOYEN D'AGONISTES DU RECEPTEUR DE LA PROSAPOSINE
Publication
Application
Priority
- US 9819216 W 19980909
- US 5835297 P 19970909
- US 8812998 P 19980604
Abstract (en)
[origin: WO9912559A1] A method for inhibiting caspase-mediated apoptosis by administering prosaposin receptor agonists is provided. Apoptosis has a major causative role in diseases such as rheumatoid arthritis, irritable bowel syndrome, congestive heart failure, multiple sclerosis, Alzheimer's disease, Parkinson's disease, myocardial infraction, and coronary ischemia.
IPC 1-7
IPC 8 full level
A61K 45/00 (2006.01); A61K 38/00 (2006.01); A61K 38/18 (2006.01); A61P 1/04 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 11/06 (2006.01); A61P 17/14 (2006.01); A61P 19/02 (2006.01); A61P 25/00 (2006.01); A61P 25/14 (2006.01); A61P 25/16 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 37/06 (2006.01); A61P 43/00 (2006.01)
CPC (source: EP)
A61K 38/18 (2013.01); A61P 1/04 (2018.01); A61P 9/04 (2018.01); A61P 9/10 (2018.01); A61P 11/06 (2018.01); A61P 17/14 (2018.01); A61P 19/02 (2018.01); A61P 25/00 (2018.01); A61P 25/14 (2018.01); A61P 25/16 (2018.01); A61P 25/28 (2018.01); A61P 29/00 (2018.01); A61P 37/06 (2018.01); A61P 43/00 (2018.01); Y02A 50/30 (2018.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9912559 A1 19990318; AU 9774698 A 19990329; CA 2304108 A1 19990318; EP 1011709 A1 20000628; EP 1011709 A4 20030618; JP 2001515866 A 20010925
DOCDB simple family (application)
US 9819216 W 19980909; AU 9774698 A 19980909; CA 2304108 A 19980909; EP 98951917 A 19980909; JP 2000510456 A 19980909